1.Non-Operative Management in Residual and Recurrent Bile Duct Stones.
Byung Do CHAI ; Hee Young YANG ; Shin SON ; Kyung Hwan PARK
Journal of the Korean Surgical Society 1999;56(3):396-402
BACKGROUND: Residual and recurrent bile duct stones after biliary surgery cause many difficult problems. and reoperation on biliary tract has limitation due to its high morbidity and mortality. In recent years, various non-operative modalities for management in residual and recurrent stone have been developed. METHODS: We analyzed 69 cases of residual and recurrent bile duct stones which were managed with non-operative modalities at the Department of surgery, Dae Dong Hospital from Jan. 1994 to Dec. 1997, and evaluated the efficacy of these modalities. RESULTS: Female exceeded male with a ratio 1.76:1. and the peak incidence of age group was 6th decade. The most common diagnostic procedure was T-tube cholangiography (53.6%). Interval between previous operation and second procedure for residual or recurrent stones was within 6 months in most cases (82%). Cholecystectomy with T-tube choledochostomy was performed most frequently in previous operation. Residual and recurrent stones were found only at common bile duct in 34 cases (49.3%) most commonly. Common bile duct stones were managed most frequently with endoscopic sphincterotomy (39.5%), but the complete removal rate was heighest in choledochoscopic stone removal (100%). Complete removal rate of intrahepatic duct stone was heighest with interventional radiologic stone removal as well as choledochoscopic stone removal (43.6%), but average number of session was smaller in choledochoscopic stone removal (2.5) than interventional radiologic stone removal (3.5). Associated complication with non-operative management modalities were very low, except three cases of hepaticocutaneous jejunostomy. The latter required reoperation due to continuous bile fistula in two cases, and long jejunal loop in one case. CONCLUSIONS: Choledochoscopic stone removal is most effective method in the management of residual and recurrent bile duct stones.
Bile Ducts*
;
Bile*
;
Biliary Tract
;
Cholangiography
;
Cholecystectomy
;
Choledochostomy
;
Common Bile Duct
;
Female
;
Fistula
;
Humans
;
Incidence
;
Jejunostomy
;
Male
;
Methods
;
Mortality
;
Reoperation
;
Sphincterotomy, Endoscopic
2.Analysis of the treatment of unexpected gallbladder cancer.
Ling ZHANG ; Feng HAN ; Chang-shan HUANG ; Chun PANG ; You-zhi HAN ; Ya-wei HUA
Chinese Journal of Surgery 2005;43(7):460-462
OBJECTIVETo investigate the secondary operation methods and the effects on the prognosis of unexpected gallbladder cancer (UGC).
METHODSA retrospective analysis on the clinical data was made for 41 patients who underwent extended radical excision from June 1995 to December 2002. Among the patients, 12 were male, 29 were female. The average age was 51 years old. The 41 patients had undergone gallbladder excision because of cholecystitis complicated lithiasis of gallbladder (32 cases), polypi of gallbladder or adenoma (9 cases). Postoperative pathology showed that 32 cases were adenocarcinoma of gallbladder, 6 cases were squamous carcinoma, 3 cases were squamous adenocarcinoma. Six cases were on the stage of Nevin I, 16 on Nevin II, 17 on Nevin III, 2 on Nevin IV. The second operation was performed after 6-30 d of the first operation. The second operation chose the improved method of Glenn excision of carcinoma of gallbladder.
RESULTSOn the second operation, 14 cases were with lymphatic metastasis, 14 with gallbladder metastasis, 6 with bile duct metastasis, 2 with pancreas metastasis. Fourteen cases were on the stage of Nevin IV, 9 on Nevin V, none on Nevin I, II and III. After the second operation, 1 year survival rate was 100% (41 cases); The three-year survival rate was 53.8% (22 cases); The five-year survival rate was 17.5% (7 cases).
CONCLUSIONExtended radical excision is one of the most important methods for the treatment of UGC.
Adult ; Aged ; Cholecystectomy ; methods ; Diagnostic Errors ; Female ; Gallbladder Neoplasms ; diagnosis ; mortality ; surgery ; Humans ; Male ; Middle Aged ; Reoperation ; Retrospective Studies ; Survival Rate
3.Practical Guidelines for the Surgical Treatment of Gallbladder Cancer.
Seung Eun LEE ; Kyung Sik KIM ; Wan Bae KIM ; In Gyu KIM ; Yang Won NAH ; Dong Hee RYU ; Joon Seong PARK ; Myung Hee YOON ; Jai Young CHO ; Tae Ho HONG ; Dae Wook HWANG ; Dong Wook CHOI
Journal of Korean Medical Science 2014;29(10):1333-1340
At present, surgical treatment is the only curative option for gallbladder (GB) cancer. Many efforts therefore have been made to improve resectability and the survival rate. However, GB cancer has a low incidence, and no randomized, controlled trials have been conducted to establish the optimal treatment modalities. The present guidelines include recent recommendations based on current understanding and highlight controversial issues that require further research. For T1a GB cancer, the optimal treatment modality is simple cholecystectomy, which can be carried out as either a laparotomy or a laparoscopic surgery. For T1b GB cancer, either simple or an extended cholecystectomy is appropriate. An extended cholecystectomy is generally recommended for patients with GB cancer at stage T2 or above. In extended cholecystectomy, a wedge resection of the GB bed or a segmentectomy IVb/V can be performed and the optimal extent of lymph node dissection should include the cystic duct lymph node, the common bile duct lymph node, the lymph nodes around the hepatoduodenal ligament (the hepatic artery and portal vein lymph nodes), and the posterior superior pancreaticoduodenal lymph node. Depending on patient status and disease severity, surgeons may decide to perform palliative surgeries.
Cholecystectomy, Laparoscopic/*methods
;
Gallbladder Neoplasms/epidemiology/mortality/*surgery
;
Humans
;
Incidental Findings
;
Laparotomy
;
Liver Neoplasms/secondary/*surgery
;
Lymph Node Excision/*methods
;
Lymph Nodes/pathology/surgery
;
Lymphatic Metastasis/*pathology
;
Survival Rate
4.Effects of Surgical Methods and Tumor Location on Survival and Recurrence Patterns after Curative Resection in Patients with T2 Gallbladder Cancer.
Woohyun JUNG ; Jin Young JANG ; Mee Joo KANG ; Ye Rim CHANG ; Yong Chan SHIN ; Jihoon CHANG ; Sun Whe KIM
Gut and Liver 2016;10(1):140-146
BACKGROUND/AIMS: Extended cholecystectomy is generally recommended for patients with T2 gallbladder cancer. However, few studies have assessed the extent of resection relative to T2 gallbladder tumor location. This study analyzed the effects of surgical methods and tumor location on survival outcomes and tumor recurrence in patients with T2 gallbladder cancer. METHODS: Clinicopathological characteristics, extent of resection, survival rates, and recurrence patterns were retrospectively analyzed in 88 patients with pathologically confirmed T2 gallbladder cancer. RESULTS: The 5-year disease-free survival rate was 65.0%. Multivariate analysis showed that lymph node metastasis was the only independent risk factor for poor 5-year disease-free survival rate. Survival outcomes were not associated with tumor location. Survival tended to be better in patients who underwent extended cholecystectomy than in those who underwent simple cholecystectomy. Recurrence rate was not affected by surgical method or tumor location. Systemic recurrence was more frequent than local recurrence without distant recurrence. Gallbladder bed recurrence and liver recurrence were relatively rare, occurring only in patients with liver side tumors. CONCLUSIONS: Extended cholecystectomy is the most appropriate treatment for T2 gallbladder cancer. However, simple cholecystectomy with regional lymph node dissection may be appropriate for patients with serosal side tumors.
Adult
;
Aged
;
Aged, 80 and over
;
Cholecystectomy/*methods/mortality
;
Disease-Free Survival
;
Female
;
Gallbladder/pathology
;
*Gallbladder Neoplasms/mortality/pathology/surgery
;
Humans
;
Lymph Node Excision
;
Lymphatic Metastasis
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local/*etiology/pathology
;
Neoplasm Staging
;
Retrospective Studies
;
Risk Factors
;
Survival Rate
;
Treatment Outcome